ASPH is reported as a malignant factor in hepatocellular carcinoma, glioma, and pancreatic cancer46–48, and its targeting reduces proliferation and invasion of prostate cancer cells through Notch signalling modulation49. This evidence concerns the gene ASPH and hepatocellular carcinoma.